NASDAQ:ADMP Adamis Pharmaceuticals - ADMP Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Adamis Pharmaceuticals Co. Please log in to your account or sign up in order to add this asset to your watchlist. $0.11 +0.00 (+2.87%) (As of 03/22/2023 11:59 AM ET) Add Compare Share Share Today's Range$0.10▼$0.1150-Day Range$0.10▼$0.3052-Week Range$0.10▼$0.64Volume327,206 shsAverage Volume1.36 million shsMarket Capitalization$16.15 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media About Adamis Pharmaceuticals (NASDAQ:ADMP) StockAdamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets. It offers the SYMJEPI Injection for the emergency treatment of allergic reactions. The company was founded in June 2006 and is headquartered in San Diego, CA.Read More Receive ADMP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ADMP Stock News HeadlinesMarch 21, 2023 | americanbankingnews.comStockNews.com Begins Coverage on Adamis Pharmaceuticals (NASDAQ:ADMP)March 20, 2023 | americanbankingnews.comAdamis Pharmaceuticals (NASDAQ:ADMP) Coverage Initiated at StockNews.comMarch 22, 2023 | Investing Daily (Ad)Check Out This 6-Year Win StreakDespite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. March 19, 2023 | finance.yahoo.comAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q4 2022 Earnings Call TranscriptMarch 17, 2023 | finance.yahoo.comQ4 2022 Adamis Pharmaceuticals Corp Earnings CallMarch 16, 2023 | msn.comAdamis Pharmaceuticals GAAP EPS of -$0.18, revenue of $4.75MMarch 16, 2023 | finance.yahoo.comAdamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate UpdateMarch 14, 2023 | finance.yahoo.comAdamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate UpdateMarch 22, 2023 | Investing Daily (Ad)Check Out This 6-Year Win StreakDespite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. March 14, 2023 | finance.yahoo.comAdamis Pharmaceuticals Announces $3.0 Million Registered Direct OfferingMarch 2, 2023 | benzinga.comShort Volatility Alert: Adamis PharmaceuticalsMarch 1, 2023 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Adamis Pharmaceuticals Corporation MergerFebruary 28, 2023 | msn.comOpioid Focused Adamis Pharma Agrees To Merge With Privately Held DMK PharmaceuticalsFebruary 28, 2023 | msn.comAdamis Pharmaceuticals jumps 36% on DMK Pharmaceuticals merger planFebruary 27, 2023 | finance.yahoo.comAdamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of MergerFebruary 22, 2023 | finance.yahoo.comNasdaq Grants Adamis Pharmaceuticals’ Request for Extension to Comply with Continued Listing RequirementsDecember 29, 2022 | finance.yahoo.comAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q3 2022 Earnings Call TranscriptNovember 15, 2022 | finanznachrichten.deAdamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 15, 2022 | seekingalpha.comAdamis Pharmaceuticals Corporation (ADMP) Q3 2022 Earnings Call TranscriptNovember 15, 2022 | finance.yahoo.comAdamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 12, 2022 | msn.comA Preview Of Adamis Pharmaceuticals's EarningsNovember 7, 2022 | finance.yahoo.comAdamis Pharmaceuticals Schedules Third Quarter 2022 Financial Results Conference Call and Corporate UpdateOctober 18, 2022 | msn.comWhy fuboTV Shares Are Trading Higher By 11%; Here Are 22 Stocks Moving PremarketOctober 12, 2022 | msn.comWhy Cango Shares Are Trading Higher; Here Are 27 Stocks Moving PremarketOctober 5, 2022 | marketwatch.comAdamis Pharmaceuticals Shares Jump 14% On Potential Sale, Strategic AlternativesOctober 3, 2022 | nasdaq.comAdamis Pharma To Explore Strategic Alternatives; Stock Up 10%October 3, 2022 | finance.yahoo.comAdamis Announces Review of Strategic AlternativesSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ADMP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ADMP Company Calendar Last Earnings3/31/2022Today3/22/2023Next Earnings (Estimated)5/15/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ADMP CUSIPN/A CIK887247 Webwww.adamispharmaceuticals.com Phone(858) 997-2400FaxN/AEmployees116Year Founded2006Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-26,480,000.00 Net Margins-556.71% Pretax Margin-550.82% Return on Equity-420.53% Return on Assets-147.30% Debt Debt-to-Equity RatioN/A Current Ratio0.81 Quick Ratio0.70 Sales & Book Value Annual Sales$4.76 million Price / Sales3.30 Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-10.47Miscellaneous Outstanding Shares149,980,000Free Float141,134,000Market Cap$15.70 million OptionableOptionable Beta1.26 Social Links Key ExecutivesDavid J. MarguglioPresident, Chief Executive Officer & DirectorDavid C. BenedictoChief Financial & Accounting OfficerThomas H. MollVice President-ResearchKey CompetitorsCelyad OncologyNASDAQ:CYADMolecular TemplatesNASDAQ:MTEMApexigenNASDAQ:APGNLannettNYSE:LCIShuttle PharmaceuticalsNASDAQ:SHPHView All CompetitorsInstitutional OwnershipGeode Capital Management LLCSold 76,375 shares on 2/13/2023Ownership: 0.885%HighTower Advisors LLCBought 61 shares on 2/9/2023Ownership: 0.000%Simplex Trading LLCBought 500 shares on 2/2/2023Ownership: 0.000%View All Institutional Transactions ADMP Stock - Frequently Asked Questions How have ADMP shares performed in 2023? Adamis Pharmaceuticals' stock was trading at $0.1693 at the start of the year. Since then, ADMP shares have decreased by 36.4% and is now trading at $0.1077. View the best growth stocks for 2023 here. Are investors shorting Adamis Pharmaceuticals? Adamis Pharmaceuticals saw a decline in short interest during the month of February. As of February 28th, there was short interest totaling 1,560,000 shares, a decline of 8.8% from the February 13th total of 1,710,000 shares. Based on an average trading volume of 1,130,000 shares, the short-interest ratio is presently 1.4 days. View Adamis Pharmaceuticals' Short Interest. When is Adamis Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 15th 2023. View our ADMP earnings forecast. How were Adamis Pharmaceuticals' earnings last quarter? Adamis Pharmaceuticals Co. (NASDAQ:ADMP) released its earnings results on Thursday, March, 31st. The specialty pharmaceutical company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.02. Adamis Pharmaceuticals had a negative net margin of 556.71% and a negative trailing twelve-month return on equity of 420.53%. During the same period in the previous year, the business posted ($0.16) EPS. What other stocks do shareholders of Adamis Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Adamis Pharmaceuticals investors own include Trevena (TRVN), Amarin (AMRN), Sorrento Therapeutics (SRNE), Verastem (VSTM), Dynavax Technologies (DVAX), Novavax (NVAX), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Agile Therapeutics (AGRX) and OPKO Health (OPK). What is Adamis Pharmaceuticals' stock symbol? Adamis Pharmaceuticals trades on the NASDAQ under the ticker symbol "ADMP." Who are Adamis Pharmaceuticals' major shareholders? Adamis Pharmaceuticals' stock is owned by many different institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (0.88%), Simplex Trading LLC (0.00%), HighTower Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include David C Benedicto, David J Marguglio, Dennis J Phd Carlo, Karen K Daniels, Robert O Hopkins and Ronald B Moss. View institutional ownership trends. How do I buy shares of Adamis Pharmaceuticals? Shares of ADMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Adamis Pharmaceuticals' stock price today? One share of ADMP stock can currently be purchased for approximately $0.11. How much money does Adamis Pharmaceuticals make? Adamis Pharmaceuticals (NASDAQ:ADMP) has a market capitalization of $16.15 million and generates $4.76 million in revenue each year. How many employees does Adamis Pharmaceuticals have? The company employs 116 workers across the globe. How can I contact Adamis Pharmaceuticals? Adamis Pharmaceuticals' mailing address is 11682 EL CAMINO REAL SUITE 300, SAN DIEGO CA, 92130. The official website for the company is www.adamispharmaceuticals.com. The specialty pharmaceutical company can be reached via phone at (858) 997-2400 or via email at mflather@adamispharma.com. This page (NASDAQ:ADMP) was last updated on 3/22/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.